Marc Vimolratana

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

26

H-Index

1

About

Dr. Marc Vimolratana is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment. His most cited work, a 2020 study on "Two-Year Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy," has garnered 26 citations, underscoring its impact on postoperative care. Dr. Vimolratana’s major contribution lies in demonstrating that robotic-assisted esophagectomy not only matches but can improve long-term quality of life compared to traditional open surgery, offering patients reduced recovery burdens without compromising oncologic outcomes. This work has helped shift clinical practice toward more patient-centered surgical approaches. Beyond this landmark paper, his research explores the intersection of surgical innovation and survivorship, emphasizing functional recovery and symptom management. Dr. Vimolratana’s achievements include integrating robotic platforms into complex thoracic procedures, influencing guidelines for esophageal cancer management. His dedication to rigorous outcomes research provides a vital evidence base for surgeons and patients navigating treatment decisions, making him a respected voice in the field of surgical oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Two-Year Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy
26 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago